200 participants
Perioperative Risk of Immunotherapy Based Neoadjuvant and Conversion Therapy for Hepatocellular Carcinoma
- Study Type:
- OBSERVATIONAL
- Last Updated:
- 2024-08-26
- Start Date:
- 2014-04-01
- Completion:
- 2025-08-01
Conditions
- Carcinoma, Hepatocellular
- Immunotherapy
No Results Yet